FBLG
FibroBiologics, Inc. Common StockNASDAQHealthcare$1.37-0.72%ClosedMarket Cap: $2.9M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.50
P/S
0.00
EV/EBITDA
-0.02
DCF Value
$1.11
FCF Yield
-580.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-785.8%
ROA
-193.8%
ROIC
-194.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-2.6M | $-3.2M | $-0.98 | — |
| FY 2025 | $0.00 | -Infinity% | $-16.6M | $-18.6M | $-8.40 | — |
| Q3 2025 | $0.00 | -Infinity% | $-5.0M | $-5.8M | $-2.60 | — |
| Q2 2025 | $0.00 | NaN% | $-4.5M | $-4.7M | $-2.40 | — |
| Q1 2025 | $0.00 | NaN% | $-4.5M | $-5.0M | $-2.80 | — |
| Q4 2024 | $0.00 | NaN% | $-3.7M | $-3.1M | $-1.78 | — |
| FY 2024 | $0.00 | NaN% | $-13.7M | $-11.2M | $-6.80 | — |
| Q3 2024 | $0.00 | NaN% | $-3.4M | $-500.0K | $-0.20 | — |
| Q2 2024 | $0.00 | NaN% | $-3.2M | $898.0K | $0.60 | — |
| Q1 2024 | $0.00 | NaN% | $-3.5M | $-8.5M | $-5.40 | — |
| Q4 2023 | $0.00 | NaN% | $-2.5M | $-9.7M | $-6.20 | — |
| FY 2023 | $0.00 | NaN% | $-8.9M | $-16.5M | $-11.80 | — |